Correlation Between Cue Biopharma and Vincerx Pharma

Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cue Biopharma and Vincerx Pharma, you can compare the effects of market volatilities on Cue Biopharma and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Vincerx Pharma.

Diversification Opportunities for Cue Biopharma and Vincerx Pharma

-0.78

Correlation Coefficient

Cue Biopharma  Vincerx Pharma

Pay attention - limited upside

The 3 months correlation between Cue and Vincerx is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Cue Biopharma and Vincerx Pharma

Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.83 times more return on investment than Vincerx Pharma. However, Cue Biopharma is 1.83 times more volatile than Vincerx Pharma. It trades about 0.13 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.2 per unit of risk. If you would invest  66.00  in Cue Biopharma on September 3, 2024 and sell it today you would earn a total of  56.00  from holding Cue Biopharma or generate 84.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cue Biopharma  vs.  Vincerx Pharma

Cue Biopharma

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Cue Biopharma and Vincerx Pharma

The main advantage of trading using opposite Cue Biopharma and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.

The idea behind Cue Biopharma and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.